Prosthesis-patient mismatch after aortic valve replacement in the PARTNER 2 trial and registry

Authors: Ternacle, JulienPibarot, Philippe; Herrmann, Howard C.; Kodali, Susheel; Leipsic, Jonathon; Blanke, Philipp; Jaber, Wael; Mack, Michael J.; Clavel, Marie-AnnickSalaun, ErwanGuzzetti, EzequielAnnabi, Mohamed SalahBernier, MathieuBeaudoin, Jonathan; Khalique, Omar K.; Weissman, Neil J.; Douglas, Pamela; Bax, Jeroen; Dahou, Abdellaziz; Xu, Ke; Alu, Maria; Rogers, Erin; Leon, Martin; Thourani, Vinod H.; Abbas, Amr E.; Hahn, Rebecca T.
Abstract: Objectives This study aimed to compare incidence and impact of measured prosthesis-patient mismatch (PPMM) versus predicted PPM (PPMP) after surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). Background TAVR studies have used measured effective orifice area indexed (EOAi) to body surface area (BSA) to define PPM, but most SAVR series have used predicted EOAi. This difference may contribute to discrepancies in incidence and outcomes of PPM between series. Methods The study analyzed SAVR patients from the PARTNER (Placement of Aortic Transcatheter Valves) 2A trial and TAVR patients from the PARTNER 2 SAPIEN 3 Intermediate Risk registry. PPM was classified as moderate if EOAi ≤0.85 cm2/m2 (≤0.70 if obese: body mass index ≥30 kg/m2) and severe if EOAi ≤0.65 cm2/m2 (≤0.55 if obese). PPMM was determined by the core lab–measured EOAi on 30-day echocardiogram. PPMP was determined by 2 methods: 1) using normal EOA reference values previously reported for each valve model and size (PPMP1; n = 929 SAVR, 1,069 TAVR) indexed to BSA; and 2) using normal reference EOA predicted from aortic annulus size measured by computed tomography (PPMP2; n = 864 TAVR only) indexed to BSA. Primary endpoint was the composite of 5-year all-cause death and rehospitalization. Results The incidence of moderate and severe PPMP was much lower than PPMM in both SAVR (PPMP1: 28.4% and 1.2% vs. PPMM: 31.0% and 23.6%) and TAVR (PPMP1: 21.0% and 0.1% and PPMP2: 17.0% and 0% vs. PPMM: 27.9% and 5.7%). The incidence of severe PPMM and severe PPMP1 was lower in TAVR versus SAVR (P < 0.001). The presence of PPM by any method was associated with higher transprosthetic gradient. Severe PPMP1 was independently associated with events in SAVR after adjustment for sex and Society of Thoracic Surgeons score (hazard ratio: 3.18;95% CI: 1.69-5.96; P < 0.001), whereas no association was observed between PPM by any method and outcomes in TAVR. Conclusions EOAi measured by echocardiography results in a higher incidence of PPM following SAVR or TAVR than PPM based on predicted EOAi. Severe PPMP is rare (<1.5%), but is associated with increased all-cause death and rehospitalization after SAVR, whereas it is absent following TAVR.
Document Type: Article de recherche
Issue Date: 5 July 2021
Open Access Date: 30 July 2021
Document version: VoR
Creative Commons Licence: https://creativecommons.org/licenses/by/4.0
Permalink: http://hdl.handle.net/20.500.11794/69762
This document was published in: JACC. Cardiovascular interventions, Vol. 14 (13), 1466-1477 (2021)
https://doi.org/10.1016/j.jcin.2021.03.069
Elsevier
Alternative version: 10.1016/j.jcin.2021.03.069
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
212 - Prosthesis-Patient Mismatch.pdf1.35 MBAdobe PDFThumbnail
View/Open
All documents in CorpusUL are protected by Copyright Act of Canada.